You should be fully aware that the approval rate of treatments for the conditions being targeted by CUV are only in the order of 5-10%.
But you make no real attempt to counter the constant BS from uninformed posters about "pre approved" drugs, fast tracking and immediate revenue streams.
Five decades of research into alpha-MSH analogues has produced virtually nothing of consequence (apart from artificial melanin production) and two obscure drugs.They have been almost totally ignored by Big Pharma Yet we are now supposed to believe that some tiny Australian company is suddenly going to bring a raft of new blockbuster drugs onto the market. It has zero plausibility.
Revenue EXPLOSION Coming?, page-64
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.68 |
Change
-0.240(1.61%) |
Mkt cap ! $735.1M | |||
| Open | High | Low | Value | Volume |
| $14.75 | $14.92 | $14.65 | $503.5K | 34.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 448 | $14.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.74 | 149 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |